Ventricular Tachycardia Pipeline Insight 2025: Innovations in Gene Therapy, Ablation Technologies, and Antiarrhythmic Drug Development | DelveInsight

The treatment landscape for ventricular tachycardia (VT) is evolving, driven by advances in mechanistic understanding and personalized care. VT, a serious arrhythmia often linked to structural heart disease or prior heart attacks, remains challenging to manage. While ICDs and catheter

Read Full Article →